Atheln, Inc

Atheln helps clients create and execute integrated pharma and biotech product development and commercialization strategies. Our approach is unique in its integration of commercial and technical disciplines to maximize product value, relentless focus on identifying the key disciplines addressing client needs, exclusively utilizing industry seasoned experts, and being solely driven by client success. This approach is rooted in our extensive hands-on experience spanning from early research to life cycle management. Our global team of over 100 highly specialized, industry-seasoned experts excel at risk identification and mitigation, while delivering phase appropriate and customized solutions that increase value and likelihood of success....

Biopharma consulting,portfolio management,bd,licensing,due diligence,market access,product development,commercial plans,lifecycle management,market analysis,regulatory affairs,cmc,quality assurance,analytics,clinical,devices,combination products,small molecules,nonclinical,process development,manufacturing,formulation development,and analytical development

Atheln, inc operates in the Biotechnology research industry.

Atheln, inc's revenue is 11m - 100m

Atheln, inc has 11 - 50 employees.